The purpose of this pamphlet is to let patients know what they can do to keep their livers healthy. It contains information about liver health lab tests, the virus and how it is spread, hepatitis A and B, sex and hepatitis C, and hepatitis C treatment. The guide also includes some useful resources for patients.
This information sheet provides information about pregnancy for women who have hepatitis C. It addresses situations for women considering pregnancy, women currently pregnant, and women who already have children.
This handbook is meant to help people work through the difficulty of being diagnosed with the hepatitis C (HCV) and turn that knowledge into ways to help people with HCV by starting a support group. It provides many practical ideas to consider while creating and maintaining a support group.
This report provides graphs that demonstrate the continuum of HIV care among persons with HIV in Alabama in 2013. Categories include the estimated number of people with HIV, those diagnosed, those linked to care, those retained in care, and those with a suppressed viral load in both the state and in each public health zone.
This monograph is a that guide that is intended to provide a basic overview of the management of viral hepatitis for clinicians who care for HIV-infected. The guide describes each type of hepatitis, modes of transmission, medications, and testing. It is not intended to be all-inclusive or take the place of established guidelines.
This information sheet is a general FAQ that features answers to posed questions. Questions include: What is hepatitis C?; How is hepatitis C spread?; What are the effects of hepatitis C?; How will I know if I have hepatitis C?; and Is there a treatment for hepatitis C?
This journal article is a practice guideline that provides recommendations summarizing the growing literature and current best practices of chronic Hepatitis C Virus (HCV) treatment, including treatment in difficult-to-treat populations. These recommendations are based on an extensive review of published data, national consensus recommendations, and input from thought leaders involved in HCV care and treatment.
This information sheet presents facts about viral hepatitis in tabular format. It discusses hepatitis A, B, and C. It lists statistics; routes of transmission; persons at risk; incubation period; symptoms of acute infection; the likelihood of symptomatic acute infection; the potential for chronic infection; the severity; serologic tests for acute and chronic infection; screening recommendations for chronic infection; treatment; vaccination recommendations and schedule, if any; and testing recommendations.
This pamphlet discusses hepatitis C virus infection (HCV) for the newly-diagnosed patient. It explains the disease including acute and chronic infection, its symptoms, effect on the liver, treatment including the two oral medications cleared by the Federal Drug Administration for patients with hepatitis C genotype 1, preventing transmission to others, treatment outcomes and complications of chronic HCV, and the outlook for people with chronic HCV. It includes a list of questions for the patient to ask his/her healthcare provider and a list of resources.
This report describes approaches for managing patients with TB who are candidates for or who are undergoing protease inhibitor therapy and presents interim recommendations for managing these patients until additional data are available and formal guidelines are issued. Protease inhibitors interact with rifamycin derivatives, which are used to treat and prevent the mycobacterial infections commonly observed in patients with the HIV. The report provides background information on the management of TB and the three treatment options currently available for these patients.